Carter Todd Alfred
Officer at VYGR
- Sold, on record
- $368k
- Dollars the filings state
- Form 4 sales
- 16
- Latest Feb 24, 2026
- Form 144 notices
- 12
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- VYGRVoyager Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 144 notice VYGRNoticeFeb 20, 2025 2025
Filed to sell 3,305 shares ($14k)
Carter Todd Alfred, Officer
No 10b5-1 plan0.7x usual sizeFiling
- 2 Form 4 sale VYGRNo planFeb 20, 2025 same day
Sold 3,305 shares at $4.26 ($14k)
Carter Todd Alfred, Chief Scientific Officer
No 10b5-1 planSold 4.1% of holdings ($345k position)77,718 shares left0.7x usual sizeFollows a Form 144Filing
- 3 Form 144 notice VYGRNoticeFeb 10, 2026 +355 days
Filed to sell 3,525 shares ($14k)
Carter Todd Alfred, Officer
No 10b5-1 plan1x usual sizeFiling
- 4 Form 4 sale VYGRNo planFeb 10, 2026 same day
Sold 3,525 shares at $3.85 ($14k)
Carter Todd Alfred, Chief Scientific Officer
No 10b5-1 planSold 2.2% of holdings ($603k position)153,193 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 144 notice VYGRNoticeFeb 18, 2026 +8 days
Filed to sell 3,301 shares ($11k)
Carter Todd Alfred, Officer
No 10b5-1 plan0.9x usual sizeFiling
- 6 Form 4 sale VYGRRoutineFeb 18, 2026 same day
Sold 3,301 shares at $3.44 ($11k)
Carter Todd Alfred, Chief Scientific Officer
10b5-1 planSold 2.2% of holdings ($527k position)149,892 shares left0.9x usual sizeFollows a Form 144Filing
- 7 Form 144 notice VYGRNoticeFeb 24, 2026 +6 days
Filed to sell 4,174 shares ($16k)
Carter Todd Alfred, Officer
No 10b5-1 plan1.3x usual sizeFiling
- 8 Form 4 sale VYGRRoutineFeb 24, 2026 same day
Sold 4,174 shares at $3.76 ($16k)
Carter Todd Alfred, Chief Scientific Officer
10b5-1 planSold 2.8% of holdings ($564k position)145,718 shares left1.3x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (28)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Feb 26, 2026 | VYGR | Chief Scientific Officer | Form 4 sale | 4,174 | $16k | 2.8% | Routine | SEC |
| Feb 24, 2026 | Feb 24, 2026 | VYGR | Officer | Form 144 notice | 4,174 | $16k | Notice | SEC | |
| Feb 18, 2026 | Feb 20, 2026 | VYGR | Chief Scientific Officer | Form 4 sale | 3,301 | $11k | 2.2% | Routine | SEC |
| Feb 18, 2026 | Feb 18, 2026 | VYGR | Officer | Form 144 notice | 3,301 | $11k | Notice | SEC | |
| Feb 10, 2026 | Feb 11, 2026 | VYGR | Chief Scientific Officer | Form 4 sale | 3,525 | $14k | 2.2% | No plan | SEC |
| Feb 10, 2026 | Feb 10, 2026 | VYGR | Officer | Form 144 notice | 3,525 | $14k | Notice | SEC | |
| Feb 20, 2025 | Feb 24, 2025 | VYGR | Chief Scientific Officer | Form 4 sale | 3,305 | $14k | 4.1% | No plan | SEC |
| Feb 20, 2025 | Feb 20, 2025 | VYGR | Officer | Form 144 notice | 3,305 | $14k | Notice | SEC | |
| Feb 11, 2025 | Feb 12, 2025 | VYGR | Chief Scientific Officer | Form 4 sale | 5,413 | $24k | 6.3% | No plan | SEC |
| Feb 11, 2025 | Feb 11, 2025 | VYGR | Officer | Form 144 notice | 5,413 | $24k | Notice | SEC | |
| Jan 14, 2025 | Jan 15, 2025 | VYGR | Chief Scientific Officer | Form 4 sale | 1,191 | $6k | 1.4% | No plan | SEC |
| Jan 14, 2025 | Jan 14, 2025 | VYGR | Officer | Form 144 notice | 1,191 | $6k | Notice | SEC | |
| Feb 21, 2024 | Feb 22, 2024 | VYGR | Chief Scientific Officer | Form 4 sale | 3,967 | $30k | 4.3% | Unusual | SEC |
| Feb 21, 2024 | Feb 21, 2024 | VYGR | Officer | Form 144 notice | 3,365 | $25k | Notice | SEC | |
| Feb 20, 2024 | Feb 20, 2024 | VYGR | Officer | Form 144 notice | 602 | $5k | Notice | SEC | |
| Jan 17, 2024 | Jan 19, 2024 | VYGR | Chief Scientific Officer | Form 4 sale | 1,266 | $9k | 2.3% | No plan | SEC |
| Jan 17, 2024 | Jan 17, 2024 | VYGR | Officer | Form 144 notice | 1,266 | $9k | Notice | SEC | |
| Sep 15, 2023 | Sep 18, 2023 | VYGR | Chief Scientific Officer | Form 4 sale | 10,500 | $86k | 16.2% | Unusual | SEC |
| Sep 15, 2023 | Sep 15, 2023 | VYGR | Officer | Form 144 notice | 10,500 | $86k | Notice | SEC | |
| Jul 6, 2023 | Jul 10, 2023 | VYGR | Chief Scientific Officer | Form 4 sale | 5,500 | $59k | 8.4% | Unusual | SEC |
| Jul 6, 2023 | Jul 6, 2023 | VYGR | Officer | Form 144 notice | 5,500 | $59k | Notice | SEC | |
| Jun 30, 2023 | Jul 5, 2023 | VYGR | Chief Scientific Officer | Form 4 sale | 5,000 | $57k | 7.1% | Unusual | SEC |
| Jun 30, 2023 | Jun 30, 2023 | VYGR | Officer | Form 144 notice | 5,000 | $57k | Notice | SEC | |
| Mar 20, 2023 | Mar 22, 2023 | VYGR | Chief Scientific Officer | Form 4 sale | 2,193 | $17k | 3.2% | No plan | SEC |
| Feb 17, 2023 | Feb 22, 2023 | VYGR | Chief Scientific Officer | Form 4 sale | 738 | $5k | 1.1% | Plan not stated | SEC |
| Feb 13, 2023 | Feb 15, 2023 | VYGR | Chief Scientific Officer | Form 4 sale | 797 | $6k | 2.3% | Plan not stated | SEC |
| Jan 17, 2023 | Jan 19, 2023 | VYGR | Chief Scientific Officer | Form 4 sale | 1,106 | $11k | 3.1% | Plan not stated | SEC |
| Jan 6, 2023 | Jan 10, 2023 | VYGR | Chief Scientific Officer | Form 4 sale | 388 | $2k | 1.1% | Plan not stated | SEC |